Adults with mild or moderate nonproliferative diabetic retinopathy on fenofibrate had nearly half the odds of progressing to vision-threatening disease, more than 40% lower odds of developing cataracts, and over two-thirds lower odds of developing diabetic macular edema compared
Private equity healthcare deals fell 18.5% in the second quarter of 2026 from a year ago, while deals in two key segments — physician practice management companies and generalist and multispecialty providers — were on pace to finish at about half of their 2025 levels, according
The FDA has approved the first RAS-targeted therapy for metastatic pancreatic cancer, offering a new treatment option for patients with previously treated disease.
Daraxonrasib (Rasonque, Revolution Medicines), an oral RAS(ON) once-daily multi-selective inhibitor, is approved
Bispecific antibodies are expanding treatment options for relapsed or refractory DLBCL—but using them effectively requires thoughtful patient selection and practical toxicity management. Follow a case-based discussion of the clinical evidence and patient-centered decisions
Despite strong recommendations that patients treated with GLP-1s get regular exercise to offset losses in lean muscle mass, patients in fact often show declines in physical activity, with sedentary behavior rates well above those of non-GLP-1 treated populations, new studies
